Skip to content
10-K

Annual Report

ClearPoint Neuro, Inc. CLPT

0001193125-26-111231

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 6, 2026 29.66M sh
Shares Diluted FY 2025 · Dec 31, 2025 28.32M sh
Shares Diluted FY 2025 · Dec 31, 2024 27.03M sh
Capex FY 2025 · Dec 31, 2025 $522K
Capex FY 2025 · Dec 31, 2024 $275K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.93M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.95M
Cash And Equivalents FY 2025 · Dec 31, 2025 $45.92M
Cash And Equivalents FY 2025 · Dec 31, 2024 $20.1M
Stockholders Equity FY 2025 · Dec 31, 2025 $28.02M
Stockholders Equity FY 2025 · Dec 31, 2024 $25.39M
Stockholders Equity FY 2025 · Dec 31, 2023 $21.17M
Current Liabilities FY 2025 · Dec 31, 2025 $10.77M
Current Liabilities FY 2025 · Dec 31, 2024 $10.35M
Total Liabilities FY 2025 · Dec 31, 2025 $69.73M
Total Liabilities FY 2025 · Dec 31, 2024 $13.8M
Current Assets FY 2025 · Dec 31, 2025 $63.6M
Current Assets FY 2025 · Dec 31, 2024 $33.36M
Total Assets FY 2025 · Dec 31, 2025 $97.75M
Total Assets FY 2025 · Dec 31, 2024 $39.19M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.90
Eps Diluted FY 2025 · Dec 31, 2024 −$0.70
Eps Basic FY 2025 · Dec 31, 2025 −$0.90
Eps Basic FY 2025 · Dec 31, 2024 −$0.70
Sga Expense FY 2025 · Dec 31, 2025 $16.5M
Sga Expense restated FY 2025 · Dec 31, 2024 $11.99M
Rd Expense FY 2025 · Dec 31, 2025 $13.9M
Rd Expense FY 2025 · Dec 31, 2024 $12.39M
Net Income FY 2025 · Dec 31, 2025 −$25.54M
Net Income FY 2025 · Dec 31, 2024 −$18.91M
Operating Income FY 2025 · Dec 31, 2025 −$24.16M
Operating Income restated FY 2025 · Dec 31, 2024 −$19.73M
Gross Profit FY 2025 · Dec 31, 2025 $22.69M
Gross Profit FY 2025 · Dec 31, 2024 $19.12M
Cost Of Revenue FY 2025 · Dec 31, 2025 $14.28M
Cost Of Revenue FY 2025 · Dec 31, 2024 $12.27M
Revenue FY 2025 · Dec 31, 2025 $36.97M
Revenue FY 2025 · Dec 31, 2024 $31.39M